Aeon Biopharma Is A Biopharmaceutical Company Focused On Developing Abp 450Prabotulinumtoxinainjection For The Treatment Of Debilitating Medical Conditionsthe Company Is Dedicated To Innovation In The Rapidly Expanding Therapeutic Botulinum Toxin Marketthis Therapeutic Only Focus Will Allow Aeon Biopharma To Advance Safe And Effective Treatment Options To Patientswhile Delivering Differentiated Economics To Payors And Physiciansthe Company Continues To Evaluate Additional Therapeutic Indications For Development Based On A Comprehensive Product Assessment Process Designed To Identify Those Indications Where It Believes Abp 450 Can Attain Clinicalregulatory And Commercial Success
